- Home
- NGS vs ALDX Comparison
NGS vs ALDX Comparison
Compare NGS & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGS
- ALDX
- Stock Information
- Founded
- NGS 1998
- ALDX 2004
- Country
- NGS United States
- ALDX United States
- Employees
- NGS N/A
- ALDX N/A
- Industry
- NGS Oilfield Services/Equipment
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- NGS Energy
- ALDX Health Care
- Exchange
- NGS Nasdaq
- ALDX Nasdaq
- Market Cap
- NGS N/A
- ALDX 133.7M
- IPO Year
- NGS 2002
- ALDX 2014
- Fundamental
- Price
- NGS $20.11
- ALDX $2.16
- Analyst Decision
- NGS Strong Buy
- ALDX Strong Buy
- Analyst Count
- NGS 1
- ALDX 2
- Target Price
- NGS $32.00
- ALDX $9.50
- AVG Volume (30 Days)
- NGS 71.1K
- ALDX 1.5M
- Earning Date
- NGS 05-12-2025
- ALDX 05-20-2025
- Dividend Yield
- NGS N/A
- ALDX N/A
- EPS Growth
- NGS 260.53
- ALDX N/A
- EPS
- NGS 1.37
- ALDX N/A
- Revenue
- NGS $156,742,000.00
- ALDX N/A
- Revenue This Year
- NGS $12.87
- ALDX N/A
- Revenue Next Year
- NGS $15.40
- ALDX N/A
- P/E Ratio
- NGS $14.68
- ALDX N/A
- Revenue Growth
- NGS 29.36
- ALDX N/A
- 52 Week Low
- NGS $16.70
- ALDX $1.14
- 52 Week High
- NGS $29.74
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- NGS 53.74
- ALDX 34.82
- Support Level
- NGS $17.63
- ALDX $1.90
- Resistance Level
- NGS $19.68
- ALDX $2.89
- Average True Range (ATR)
- NGS 1.00
- ALDX 0.23
- MACD
- NGS 0.28
- ALDX 0.10
- Stochastic Oscillator
- NGS 90.51
- ALDX 26.26
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.